Genpact Limited  

(Public, NYSE:G)   Watch this stock  
Find more results for G
17.40
+0.04 (0.23%)
Aug 29 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 17.21 - 17.47
52 week 13.68 - 20.36
Open 17.43
Vol / Avg. 456,751.00/594,752.00
Mkt cap 3.76B
P/E 18.57
Div/yield     -
EPS 0.94
Shares 216.33M
Beta 1.04
Inst. own 89%
Nov 4, 2014
Q3 2014 Genpact Ltd Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Sep 9, 2014
Genpact Ltd at Deutsche Bank Technology Conference - 6:20PM EDT - Add to calendar
Jul 31, 2014
Q2 2014 Genpact Ltd Earnings Call - Webcast
Jul 31, 2014
Q2 2014 Genpact Ltd Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 8.71% 11.02%
Operating margin 13.01% 14.35%
EBITD margin - 17.05%
Return on average assets 7.28% 8.88%
Return on average equity 14.92% 18.44%
Employees 63,600 -
CDP Score - -

Address

Canon's Court, 22 Victoria Street
HAMILTON, HM 12
Bermuda
+1-441-2952244 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Genpact Limited (Genpact), is engaged in business process management and information technology services, leveraging the power of processes, analytics and technology to help its clients drive intelligence across their enterprises. The Company's core vertical activities for the Company's clients include banking and insurance, capital markets, consumer goods and retail, life sciences, infrastructure, manufacturing and services and healthcare. In addition to these vertical activities, the Company's end-to-end process expertise spans a number of service areas, including finance and accounting services, Smart Decision Services, which are consists of analytics and research, business consulting, enterprise risk consulting and re-engineering, supply chain and procurement services, enterprise application services, information technology (IT) management services and collections and customer services. In May 2014, Genpact Ltd acquired Pharmalink Consulting.

Officers and directors

N. V. Tyagarajan President, Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Edward J. Fitzpatrick CPA Chief Financial Officer
Age: 47
Bio & Compensation  - Reuters
Victor Guaglianone Senior Vice President, General Counsel, Corporate Secretary
Age: 58
Bio & Compensation  - Reuters
Piyush Mehta Senior Vice President - Human Resources
Age: 45
Bio & Compensation  - Reuters
Mohit Bhatia Senior Vice President - Internal Transformation
Age: 49
Bio & Compensation  - Reuters
Patrick Cogny Senior Vice President - Infrastructure, Manufacturing and Services
Age: 47
Bio & Compensation  - Reuters
Arvinder Singh Senior Vice President, Capital Markets and IT Services
Age: 49
Bio & Compensation  - Reuters
Mohit Thukral Senior Vice President - Banking, Financial Services, Insurance and Healthcare
Age: 48
Bio & Compensation  - Reuters
Robert G. Scott Independent Non-Executive Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Amit Chandra Independent Director
Age: 45
Bio & Compensation  - Reuters